Topline
Juul will receive authorization from the Food and Drug Administration for its e-cigarettes, the company told Forbes on Thursday, marking a reversal of fortune for the embattled company after it faced a marketing ban from the agency that only lifted last year, and had to pay out over $300 million to consumers after settling a class action lawsuit.
The e-cigarette company paid out over $300 million to customers after settling a class action … More
Key Facts
In a statement sent to Forbes, Juul confirmed that they received marketing granted orders from the FDA.
The approval came after “rigorous evaluation of the data,” Juul said.
The authorization extends to Juul’s original vape product, as well as its refill cartridges for tobacco and menthol flavors, sources told the Wall Street Journal.
The Department of Health and Human Services did not immediately respond to a request for comment from Forbes.